Abstract
Multiple sclerosis (MS) is characterized by a relapsing and remitting course, particularly in the early phases of the disease. Tests of immune function conducted both on peripheral blood and spinal fluid strongly suggest that aberrant immune function occurs in MS patients. These aberrancies appear to be most striking during periods of active disease, although they may at times remain detectable during periods of clinical quiescence. For example, in studies of sensitivity of peripheral blood or cerebrospinal fluid (CSF) lymphocytes to myelin antigens, the most striking changes have been reported in patients with active disease. Similarly, changes in the percent of B and/or T cells in peripheral blood have been most evident when disease is active. Oger et al. [14] in contrast, have found that depressed numbers of avid T cells, probably representing a T-cell subset, are observed both when disease is active and when it is quiescent. Noronha et al. [13] have presented evidence that CSF lymphocytes of MS patients remain activated as measured by RNA/DNA content, even during seemingly quiescent disease. The possibility that MS is seldom “burned out” must be seriously entertained.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abdou NI, Sagawa A, Pascual E, Hebert J, Sadeghee S (1976) Suppressor T-cell abnormality in idiopathic systemic lupus erythematosus. Clin Immunol Immunopathol 6:192
Antel JP, Arnason BGW (1979) Suppressor cell function in man: Evidence for altered sensitivity of responder cells with age. Clin Immunol Immunopathol 13:119
Antel JP, Arnason BGW, Medof ME (1979) Suppressor cell function in multiple sclerosis: Correlation with clinical disease activity. Ann Neurol 5:338
Antel JP, Richman DP, Medof ME, Arnason BGW (1978) Lymphocyte function and the role of regulator cells in multiple sclerosis. Neurology 28:106
Antel JP, Weinrich M, Arnason BGW (1978) Mitogen responsiveness and suppressor cell function in multiple sclerosis. Neurology 28:999
Bresnihan B, Jasin HE (1977) Suppressor function of peripheral blood mononuclear cells in normal individuals and patients with systemic lupus erythematosus. J Clin Invest 59:106
Broder S, Poplack D, Whang-Peng J, Durm M, Goldman C, Muul L, Waldman TA (1978) Characterization of a suppressor cell leukemia. N Engl J Med 298:66
Goust JM, Carnes JE, Chenais F, Haimes CG, Fudenberg HH, Hogan EL (1978) Abnormal T-cell subpopulations and circulating immune complexes in the Guillain-Barre syndrome and multiple sclerosis. Neurology (Minneap) 28:421
Green JA, Copperband SR, Rutstein JA, Kibrick S (1970) Inhibition of target cell proliferation by supernatants from cultures of human peripheral lymphocytes. J Immunol 105:48
Horowitz S, Borcherding W, Moorthy AV, Chesney R, Schulte-Wissermann H, Hong R, Goldstein A (1977) Induction of suppressor T cells in systemic lupus erythematosus by thymosin and cultured thymic epithelium. Science 197:999
Krakauer RS, Strober W, Rippeon DL, Waldman TA (1977) Prevention of autoimmunity in experimental lupus erythematosus by soluble immune response suppressor. Science 196:56
Moretta L, Webb SR, Grossi CE, Hydyard PM, Cooper MD (1977) Functional analysis of two human T-cell subpopulations — help and suppression of B-cell responses by T cells bearing receptors for IgM (T M ) or IgG (T G )J Exp Med 146:184
Noronha AB, Richman DP, Atchley CE, Arnason BGW (to be published) Detection of in vivo stimulated cerebrospinal fluid lymphocytes in multiple sclerosis by flow cytofluorometry
Oger JF, Arnason BGW, Wray SH, Kistler P (1975) A study of B and T cells in multiple sclerosis. Neurology (Minneap) 25:444
Richman DP, Dropcho EJ, Antel JP, Arnason BGW (to be published) Contrasting defects of T-lymphocyte mitogenic response in multiple sclerosis and myasthenia gravis. Trans Am Neurol Assoc
Sakane T, Green I (1977) Human suppressor T cells induced by concanavalin A: Suppressor T cells belong to distinctive T cell subclasses. J Immunol 119:1169
Shou L, Schwartz SA, Good RA (1976) Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J Exp Med 143:1100
Siegal FP, Siegal M, Good RA (1977) Role of helper, suppressor and B-cell defects in the pathogenesis of the hypogammaglobulinemias. N Engl J Med 299:172
Tada T, Taniguchi M, David CS (1976) Properties of the antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse IV. Special subregion assignment of the gene(s) that codes for the suppressive T cell factor in the H-2 histocompatibility system. J Exp Med 144:713
Waldman TA, Broder S, Blaise RM, Durm M, Blackman M, Strober W (1974) Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinemia. Lancet II:609
Williams RC Jr, Korsmeyer SJ (1978) Studies of human lymphocyte interaction with emphasis on soluble suppressor activity. Clin Immunol Immunopathol 9:335
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Antel, J.P., Arnason, B.W. (1980). Suppressor Lymphocyte Function During Attacks of Multiple Sclerosis. In: Bauer, H.J., Poser, S., Ritter, G. (eds) Progress in Multiple Sclerosis Research. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67554-6_52
Download citation
DOI: https://doi.org/10.1007/978-3-642-67554-6_52
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-67556-0
Online ISBN: 978-3-642-67554-6
eBook Packages: Springer Book Archive